Liquidia Corp. (LQDA)
56.97
+0.04
(+0.07%)
USD |
NASDAQ |
May 18, 16:00
56.96
-0.02
(-0.03%)
After-Hours: 20:00
Liquidia Research and Development Expense (Quarterly) : 12.27M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 10.60M |
| Indivior Pharmaceuticals, Inc. | 9.00M |
| Lexicon Pharmaceuticals, Inc. | 12.65M |
| Terns Pharmaceuticals, Inc. (DELISTED) | 18.90M |
| Emmaus Life Sciences, Inc. | 0.04M |